Mario Schlosser sold $23M of OSCR
President of Technology & CTO at Oscar Health, Inc.. 750,000 shares at an average of $30.43, traded Aug 27, 2026, filed Aug 31, 2026.
Score components
- +15RoleDirector
- +25Trade size$22.8M at market
- +20Share of holdings soldSold 69% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001844320-26-000016, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | CConversion Class A Common Stock | +600,000 | - | - | 1,080,866 | Aug 31, 2026 |
| Aug 27, 2026 | SOpen-market sale Class A Common Stock | -600,000 | $30.34 | $18M | 480,866 | Aug 31, 2026 |
| Aug 28, 2026 | CConversion Class A Common Stock | +150,000 | - | - | 630,866 | Aug 31, 2026 |
| Aug 28, 2026 | SOpen-market sale Class A Common Stock | -150,000 | $30.79 | $4.6M | 480,866 | Aug 31, 2026 |
| Aug 27, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -600,000 | $0.00 | $0 | 3,140,000 | Aug 31, 2026 |
| Aug 27, 2026 | MOption exercise Class B Common Stockderivative | +600,000 | $9.75 | $5.8M | 1,812,293 | Aug 31, 2026 |
| Aug 27, 2026 | CConversion Class B Common Stockderivative | -600,000 | $0.00 | $0 | 1,212,293 | Aug 31, 2026 |
| Aug 28, 2026 | MOption exercise Stock Option (Right to Buy)derivative | -150,000 | $0.00 | $0 | 2,990,000 | Aug 31, 2026 |
| Aug 28, 2026 | MOption exercise Class B Common Stockderivative | +150,000 | $9.75 | $1.5M | 1,362,293 | Aug 31, 2026 |
| Aug 28, 2026 | CConversion Class B Common Stockderivative | -150,000 | $0.00 | $0 | 1,212,293 | Aug 31, 2026 |
Related signals
Other insiders at Oscar Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 22Weak | Oscar Health, Inc. | Vanessa Ames Wittman director | $806k 25,000 shares | -18% | |
| 15Weak | Oscar Health, Inc. | Victoria Baltrus Chief Accounting Officer | $30k 958 shares | -0% | |
| 41Moderate | Oscar Health, Inc. | Richard Scott Blackley Chief Financial Officer | $908k 28,869 shares | -3% | |
| 30Weak | Oscar Health, Inc. | Janet Liang President, Oscar Insurance | $326k 10,360 shares | -4% | |
| 24Weak | Oscar Health, Inc. | Adam McAnaney Chief Legal Officer | $286k 9,092 shares | -4% | |
| 35Weak | Oscar Health, Inc. | Mario Schlosser President of Technology & CTO | $988k 31,422 shares | -7% | |
| 59Moderate | Oscar Health, Inc. | Richard Scott Blackley Chief Financial Officer | $595k 18,750 shares | -25% | |
| 48Moderate | Oscar Health, Inc. | Mario Schlosser President of Technology & CTO | $1.5M 47,500 shares | -100% | |
| 43Moderate | Oscar Health, Inc. | Mark T Bertolini Chief Executive Officer | $36M 1,238,996 shares | -14% | |
| 43Moderate | Oscar Health, Inc. | Mark T Bertolini Chief Executive Officer | $35M 1,206,310 shares | -12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.